
|Articles|December 1, 2003
FDA Panel Gives Nod to Wrinkle Fighters
Washington - The FDA advisory panel reviewing Hylaform and Restylane, the newest upstarts in the battle against wrinkles and scars, recommended each for approval, with conditions, by a 6-3 vote November 21.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications
2
Off-Label Case Series: Topical Roflumilast for Mild HS
3
Recludix Pharma’s REX-8756 for Type 2 Inflammatory Diseases Enters First Human Trials
4
Comparative Analysis Positions Zasocitinib Among Next-Generation TYK2 Inhibitors
5


















